Acuitive Technologies
Allendale, US · New Jersey corporation
Acuitive Technologies is an orthopedic medical device company developing products using citrate-based biodegradable biomaterials for regenerative applications, including foot and ankle surgery. Its team consists of veterans of the orthopedic industry drawn from companies such as J&J, Zimmer, Stryker, and MAKO.
Founders & leadership
MP
Michael P. McCarthyNamed on SEC filing
DS
David S. WashburnNamed on SEC filing
AK
Alex KhowayloNamed on SEC filing
MM
Mike McCarthyCEO and President
DW
Dave WashburnCOO and CFO
Reported raises · per SEC filings
Form D private placements$22.5M disclosed across 3 rounds · 2021–2023
▶$13MraisedDec 2023 · 1 investors · Other Health CareRule 506(b)
▶$13MraisedDec 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alex KhowayloExecutive Officer, Director
- David S. WashburnExecutive Officer, Director
- Gary FischettiDirector
- James MaylayterDirector
- Vincent ForlenzaDirector
- Michael McCarthyExecutive Officer, Director
- Offering amount
- $18.5M
- Amount sold
- $13M
- Finders' fees
- $200K
- Placement agents
- Kenneth J. White
- First sale
- Dec 2023
- Incorporated
- Corporation, New Jersey
- Federal exemptions
- 06b
▶$5.8MraisedJun 2023 · 17 investors · Other Health CareRule 506(b)
▶$5.8MraisedJun 2023 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael P. McCarthyExecutive Officer
- David S. WashburnExecutive Officer
- Alex KhowayloExecutive Officer
- Offering amount
- $6.2M
- Amount sold
- $5.8M
- Minimum investment
- $25K
- Sales commissions
- $52K
- Placement agents
- Alere Financial Partners, a division of Cova Capital Partners, LLC
- First sale
- Jul 2022
- Incorporated
- Corporation, New Jersey
- Federal exemptions
- 06b
▶$3.8MraisedMay 2022 · 35 investors · Other Health CareRule 506(b)
▶$3.8MraisedMay 2022 · 35 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David S. WashburnExecutive Officer
- Michael P. McCarthyExecutive Officer
- Alex KhowayloExecutive Officer
- Offering amount
- $4M
- Amount sold
- $3.8M
- Minimum investment
- $25K
- Sales commissions
- $86.7K
- Placement agents
- Alere Financial Partners, a division of Cova Capital Partners, LLC
- First sale
- May 2021
- Incorporated
- Corporation, New Jersey
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Acuitive Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Acuitive Technologies do?
- Acuitive Technologies is an orthopedic medical device company developing products using citrate-based biodegradable biomaterials for regenerative applications, including foot and ankle surgery. Its team consists of veterans of the orthopedic industry drawn from companies such as J&J, Zimmer, Stryker, and MAKO.
- How much funding has Acuitive Technologies raised?
- Acuitive Technologies has disclosed $22.5M raised across 3 rounds.
- Where is Acuitive Technologies headquartered?
- Acuitive Technologies is headquartered in Allendale, US.
